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Health impact simulation models are used to predict how a proposed intervention or scenario will affect public 
health outcomes, based on available data and knowledge of the process.  The outputs of these models are 
uncertain due to uncertainty in the structure and inputs to the model.  In order to assess the extent of uncertainty 
in the outcome we must quantify all potentially relevant uncertainties.  Then to reduce uncertainty we should 
obtain and analyse new data, but it may be unclear which parts of the model would benefit from such extra 
research.   
This paper presents methods for uncertainty quantification and research prioritisation in health impact models 
based on Value of Information (VoI) analysis. Specifically, we  
1. discuss statistical methods for quantifying uncertainty in this type of model, given the typical kinds of data that 
are available, which are often weaker than the ideal data that are desired; 
2. show how the expected value of partial perfect information (EVPPI) can be calculated to compare how 
uncertainty in each model parameter influences uncertainty in the output; 
3. show how research time can be prioritised efficiently, in the light of which components contribute most to 
outcome uncertainty. 
The same methods can be used whether the purpose of the model is to estimate quantities of interest to a policy 
maker, or to explicitly decide between policies.  We demonstrate how these methods might be used in a model of 
the impact of air pollution on health outcomes.  
Introduction 
To predict the impact on public health of an intervention or policy, simulation models are often 
used.  Under the intervention or policy, one or more health outcomes (e.g. lung cancer, stroke) 
is modified, typically through modifying one or more risk factors (e.g. physical inactivity, air 
pollution).  Models bring together multiple sources of data and assumptions, describe the 
mechanisms by which risk factors and outcomes are affected, and calculate one or more 
estimates of the overall health impact.  A simplified example is given in Figure 1, drawn from a 
model (the “Integrated Transport and Health Impact Model (ITHIM)” (1)) that examines feasible 
changes in transport behaviours and/or policies.  These changes are assumed to affect health 
through three pathways: physical activity related to active transport (e.g. bicycling and 
walking), exposure to air pollution, and road-traffic injuries.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Predictions from the models naturally have uncertainty.  The processes being modelled can 
never be known perfectly, and the data informing the model are typically weaker than the 
“ideal” data desired, in terms of sample size, potential biases or relevance.  However, it is 
possible to learn which inputs to the model most influence uncertainty in the outcome, and 
therefore prioritise further research or data collection.  
Literature on quantifying uncertainty in decision models for health economic evaluation (e.g. 
(2-4)) recommends that, where possible, uncertainties are represented by model parameters, 
which are given probability distributions. We follow this framework, where a model is 
represented as a function 𝑓𝑓 mapping a set of uncertain quantities 𝑋𝑋 to a set of outputs 𝑌𝑌 =
𝑓𝑓(𝑋𝑋). A probability distribution is placed on 𝑋𝑋 to represent uncertainty about the inputs. The 
implied distribution on 𝑌𝑌 is typically computed by Monte Carlo simulation. Constructing such 
functions and distributions can be particularly challenging in simulation models for public 
health impacts, since the interventions or scenarios of interest can affect multiple diseases, 
through multiple risk factors and pathways, thus requiring many sources of data and potential 
uncertainty to be parameterised (as reviewed in e.g. (5)). 
This probabilistic framework forms the basis for Value of Information analysis, which has been 
used extensively in health economic decision modelling (6) to estimate the potential health 
economic benefits from gaining more information about an uncertain model quantity.   
However, these methods are underused in health impact modelling, where models can be used 
for broader purposes (7).  In health economic decision models, the decision maker faces a 
choice between a discrete set of interventions and chooses to adopt the intervention with the 
maximum expected net benefit (8). In health impact modelling, the “output” is not necessarily a 
Figure 1. Integrated Transport and Health Impact Model (ITHIM). The data are 
represented by blue nodes. The model defines the outcome (burden of disease) 
as a function of input data. 
discrete decision, but is commonly a set of estimates of expected health outcomes under 
different potential circumstances. The theory of how VoI can be formulated and calculated for a 
model used for estimation rather than discrete decision making was described in (9), drawing 
ideas from sensitivity analysis in computer models (10,11), Bayesian experimental design (12), 
and VoI computation for discrete decisions (13). 
In this paper, we show how VoI methods can be applied in health impact models.  As using VoI 
methods depend on quantifying uncertainty probabilistically, we discuss how this can be done 
in typical situations. Most commonly, the available data are potentially biased or represent a 
slightly different setting compared to the ideal data.  In the next section, we discuss a range of 
statistical models that can represent the relation of the observed data to the quantity of 
interest, while naturally producing a probabilistic representation of uncertainty.  For example, 
hierarchical models can be used to inform parameters for which there are data from multiple 
related settings. In the following section, we describe VoI methods, and recommend a general 
procedure for how they might be used to prioritise further research to strengthen the evidence 
base of a typical health impact model.  
Finally, we illustrate these ideas in an artificial example adapted from the air pollution module 
of ITHIM São Paulo (1, 14).  The model calculates changes in expected deaths and disability 
under different scenarios of travel patterns.  In this model, disease risk is modelled as a 
function of air pollution exposure; air pollution exposure is a function of background air 
pollution and ventilation rate; ventilation rate is a function of the individual's travel pattern, 
and background air pollution is a function of the population's travel patterns.  Full details are 
given in the Appendix. We adapt the example from the version published in (14) to emulate a 
hypothetical new setting where an appropriate model structure has been agreed but some 
parameters are uncertain.  We illustrate how probabilistic modelling of uncertainty, combined 
with Value of Information analysis, can help to identify the parts of the model where 
uncertainty has the greatest impact on the model output, thus to prioritise the available 
research time to better inform the model. 
Uncertainty quantification in health impact models 
The uncertainty in a model output depends on how uncertainty about the model parameters is 
specified. In this section, we give general principles for quantifying common types of 
uncertainty in health impact models. The types of uncertainties we consider arise from 
incomplete knowledge of the processes being modelled or populations represented (‘epistemic’ 
uncertainties), which may in principle be reduced by obtaining more data.  We quantify 
uncertainty as probability distributions for model parameters, to enable VoI methods to be 
used to prioritise further research.  Statistical models are used to describe the relation between 
the observed data and the model parameter, and if Bayesian inference is used then a 
probability distribution representing plausible values for the parameter arises naturally.   
We focus on a common challenge in health impact models: that the relevance and the quality 
of the observed data may vary. We briefly review potentially useful methods from the 
literature, and in the Appendix two of these methods are illustrated in the context of our 
example pollution model.  Note that in any of these methods, there may still be “structural” 
uncertainty about the choice of statistical models or distributions to employ – to handle these, 
in general, we recommend flexible models that ensure that all potential sources of uncertainty 
are characterised as parameters with probability distributions, as discussed in e.g. (4).  
 
Using published data directly 
The “gold standard” for informing a model parameter would be to use data that are 
representative and unbiased. This could be a published point estimate, with a confidence / 
credible interval or standard error that reflects the size of the population used to calculate the 
estimate. In these cases, statistical principles (see e.g. (3,6)) can provide an appropriate 
distribution around the parameter, for example one with standard deviation equal to the 
reported standard error. In principle, if we were to observe a larger population from the same 
source, the uncertainty would decrease. 
  
Using reported estimates of parameters directly with inflated variance 
If published parameter estimates are nominally representative, i.e. measure directly the 
quantity of interest, but are potentially biased due to a small sample, flawed study conduct, or 
insufficient documentation (including data that report only point estimates without 
uncertainties), then we might choose to use a distribution with a greater variance than the 
reported one.  This is equivalent to replacing a model parameter X by X+d, where the 
distribution for X comes from the published data, and d is a bias term whose mean and variance 
depend on the expected amount and direction of bias, which would require a case-by-case 
judgement (see e.g. 27,28). 
 
Using published data indirectly   
In the absence of data on our parameter of interest, we can use data that nominally represent 
something slightly different from what we require, for example data from a similar but not 
identical population, time period or place, or measurements of a slightly different but related 
outcome.  It is a matter of judgement whether the data are “similar enough” to be considered 
direct estimates of the parameter, if they represent the quantity of interest but with an 
unknown degree of bias, or if their difference from what is required can be explained.  If the 
difference can be explained, instead of arbitrarily inflating a variance, we can specify a 
statistical model that defines the relationship between the data and the parameter of interest.  
Bayesian inference naturally produces a quantification of uncertainty as the posterior 
distribution for the parameter.  
Health impact models often involve risk factors, such as diet, physical activity and pollution, 
which are hard to define and measure.  How to quantify uncertainty depends on the purpose of 
the analysis. For air pollution, for example, the available data may be at the wrong level of 
aggregation, as well as for the wrong place and time: an area-level average may only be 
available where an individual-level local measurement is wanted (“Berkson” measurement 
error), or vice versa (“classical” error), or there may be uncertainty in how to combine observed 
data with model outputs (15). In each case, developing a statistical model for how all quantities 
are related will lead to a better reflection of uncertainty (see, e.g (15-18)).  For physical activity, 
reported units of measurement may vary, and synthesising all available data may require 
converting to a standard unit, e.g. marginal metabolic equivalent of task (MMET) h/week (19) 
— the associated uncertainty might be quantified using a regression model fitted to data where 
both the reported unit and the standard unit were observed. Bayesian latent variable models 
have also been used in models of physical activity interventions (20) and for dietary exposures 
(21). 
 
Combining data sources 
If there are data from multiple sources on the same parameter, they may be combined using 
statistical methods such as meta-analysis.  Multiple data sources could vary in how 
representative they are of the quantity of interest.  For example, suppose we do not have data 
for our setting of interest, but we do have data for multiple similar settings, then the observed 
variation between settings indicates the uncertainty about the setting of interest.  This 
principle, illustrated in our ITHIM example, can be expressed formally through a hierarchical 
model (17,22), also known as a multilevel, random effects or mixed effects model. A 
hierarchical meta-analysis is used in the example to estimate the background air pollution 
concentration for a city by combining a weak prior distribution with data from other cities in 
the region, leading to an assessment of uncertainty that draws on the available data. If 
predictors of differences between settings are recorded, then corresponding regression terms 
may be included in the model. In general, a hierarchical model can be designed to reflect beliefs 
about any similarities or biases that are expected in particular data sources, for example, meta-
analyses can be bias-adjusted to downweight studies thought to have lower rigour or relevance 
(23). 
 
Sometimes a quantity of interest will vary smoothly and continuously between settings, for 
example, changes in exposure to risk over time or space, or between people of different ages. 
Information from the point of interest may be strengthened by combining with nearby 
measurements, while observations that are too distant might simply be excluded. There is a 
large literature on spatial statistical modelling of disease exposures and outcomes, see. e.g. 
(24,25). A typical approach is to represent correlations between area-level outcomes through 
random effects as part of a hierarchical model. These effectively downweight data that are 
further away from the place of interest — our example might have been extended in this way. 
Similar models can represent correlations in time.  Non-linear regression can be used to 
explicitly model how a quantity depends on time or age. This allows weak data from a particular 
time to be strengthened using data from nearby times, under the assumption that the time 
trend follows some functional form. Splines and related methods (26) can model trends both 
flexibly and parsimoniously, though we must be judicious in extrapolating beyond the data.  
 
Choosing a conservatively wide distribution in the absence of data  
Sometimes there will be no data to inform a model parameter, or we may be not be willing to 
make the assumptions required to use any indirectly related data. To enable VoI methods, we 
recommend that a conservatively wide distribution is chosen for the parameter which might 
overestimate, but is unlikely to underestimate, the extent of uncertainty (27,28).  A low VoI 
would then allow further research on this parameter to be confidently ruled out.  Further 
research for a weakly informed parameter might involve structured expert elicitation (see (29) 
for instruction, or (30) for an air-pollution–specific example).  
 
Value of Information 
Value of Information (VoI) analysis measures the extent to which reduction of uncertainty in 
model parameters reduces uncertainty in the output of a model. It is used in health economic 
modelling (6), where the purpose of the model is to choose between a set of policy decisions 
𝑑𝑑 = 1, . . . ,𝐷𝐷. The optimal decision minimises the expected loss 𝐿𝐿(𝑑𝑑,𝑋𝑋) (or maximises the net 
benefit) under current information about 𝑋𝑋. The “current information” is quantified by the 
uncertainty distributions defined for 𝑋𝑋. The expected loss under the optimal decision is 
therefore 𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑𝐸𝐸𝑋𝑋{𝐿𝐿(𝑑𝑑,𝑋𝑋)}, which is expected to reduce when further information is collected 
to reduce uncertainty around 𝑋𝑋. 
Here, we use the expected value of partial perfect information (EVPPI) for a particular 
parameter or group of parameters 𝑋𝑋𝑖𝑖, which is the expected reduction in loss if we were to 
learn 𝑋𝑋𝑖𝑖, while the other parameters 𝑋𝑋−𝑖𝑖 remain uncertain: 
𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐼𝐼𝑋𝑋𝑖𝑖 = 𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑 𝐸𝐸𝑋𝑋{𝐿𝐿(𝑑𝑑,𝑋𝑋)} − 𝐸𝐸𝑋𝑋𝑖𝑖 �𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑 𝐸𝐸𝑋𝑋−𝑖𝑖|𝑋𝑋𝑖𝑖{𝐿𝐿(𝑑𝑑,𝑋𝑋𝑖𝑖,𝑋𝑋−𝑖𝑖)}�.                 (1) 
However, in health impact models, there is not always a decision between finite options. The 
aim is commonly to estimate the expected health gains 𝑌𝑌 = 𝑓𝑓(𝑋𝑋) from a potential scenario, 
under uncertainty. Decision-theoretic principles can still be used to obtain the EVPPI (9). The 
“decision” 𝑑𝑑 in this case is the choice of estimate 𝑌𝑌
̂
 for 𝑌𝑌, and the “loss” can be taken as the 
inaccuracy of this estimate. Specifically, under a squared error loss 𝐿𝐿 �𝑌𝑌
̂ ,𝑌𝑌� = �𝑌𝑌̂ − 𝑌𝑌�2, the 
optimal estimate is 𝑌𝑌
̂ = 𝐸𝐸𝑋𝑋(𝑌𝑌), the mean of 𝑌𝑌 with respect to uncertainty about 𝑋𝑋, which can 
be estimated by Monte Carlo, as the average of 𝑅𝑅 simulations 𝑌𝑌(𝑟𝑟) = 𝑓𝑓�𝑋𝑋(𝑟𝑟)�, 𝑟𝑟 = 1, … ,𝑅𝑅, 
where 𝑋𝑋(𝑟𝑟) are samples from the uncertainty distribution of 𝑋𝑋. The expected loss under current 
information is the variance of 𝑌𝑌, that is 𝑣𝑣𝑣𝑣𝑟𝑟𝑋𝑋(𝑌𝑌) = 𝐸𝐸𝑋𝑋. 
The EVPPI for 𝑋𝑋𝑖𝑖 is then the expected reduction in variance in 𝑌𝑌 if 𝑋𝑋𝑖𝑖 were to be learnt precisely. 
𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐼𝐼𝑋𝑋𝑖𝑖 = 𝑣𝑣𝑣𝑣𝑟𝑟𝑋𝑋(𝑌𝑌) − 𝐸𝐸𝑋𝑋𝑖𝑖�𝑣𝑣𝑣𝑣𝑟𝑟(𝑌𝑌|𝑋𝑋𝑖𝑖)�                                        (2) 
This can be interpreted as the amount of uncertainty in 𝑌𝑌 explained by uncertainty about 𝑋𝑋𝑖𝑖.   
This could also be expressed as a percentage of variance explained, 100 × 𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐼𝐼𝑋𝑋𝑖𝑖 𝑣𝑣𝑣𝑣⁄ 𝑟𝑟𝑋𝑋(𝑌𝑌), 
or as a predicted reduction in standard deviation, as �𝑣𝑣𝑣𝑣𝑟𝑟𝑋𝑋(𝑌𝑌) −�𝐸𝐸𝑋𝑋𝑖𝑖�𝑣𝑣𝑣𝑣𝑟𝑟(𝑌𝑌|𝑋𝑋𝑖𝑖)�.  
This method has been used for sensitivity analysis in computer modelling (10), and, as we have 
described, it has a Bayesian decision-theoretic justification. The parameter with the highest 
EVPPI is interpreted as the one for which obtaining extra data would lead to the greatest 
improvement in precision for the estimate of health gains. In our ITHIM example, the output of 
interest is the expected number of premature deaths averted in the “best case” air pollution 
reduction scenario. 
If there are 𝑅𝑅 outcomes of interest 𝑌𝑌𝑟𝑟: 𝑟𝑟 = 1, … ,𝑌𝑌𝑅𝑅, then we could calculate a different VoI for 
each 𝑌𝑌𝑟𝑟. Alternatively we could define a “generalised variance” to use in place of the variance in 
the definition of EVPPI, that gives an overall measure of uncertainty about all outcomes 
simultaneously, e.g. as the sum of the variances, potentially weighted if some outcomes are 
judged to be more important than others. See (9) for more details. 
The EVPPI expressions in Equations 1 and 2 above can be estimated, given a sample of values 
from the uncertainty distributions of the model inputs, and a corresponding sample for the 
model outputs, by using regression. This is illustrated in the Appendix — note that this can be 
done in two lines of R code. 
 
Figure 2. Model improvement and research prioritisation through Value of Information methods 
 Using VoI to prioritise model improvements 
Research to obtain additional data, and any subsequent statistical modelling , require time and 
resources, and may not ultimately affect the final results.  VoI methods can be used to guide 
model development by targeting components of the model for which further data is expected 
to improve the precision of the final results. We recommend the following process, illustrated 
in Figure 2: 
1. Develop the model structure, including every potentially important quantity as a 
parameter. 
2. Define the outcome(s) of interest, or the decision, arising from the model. 
3. Obtain distributions representing uncertainty about each parameter, based on available 
data, using a generous or conservatively wide distribution if the choice is unclear. If 
informal sensitivity analysis suggests a parameter value might not affect the results of the 
model, it can be excluded from VoI analysis. 
4. Calculate EVPPI for each model parameter. If any have low EVPPI, so that better 
information on them would not strengthen the final result of the model, then further 
research on them is not worthwhile for this model. 
5. Return to Step 3 and undertake further data collection and modelling to inform any 
parameters with substantial EVPPI. 
The judgement of what EVPPI is deemed substantial enough to deserve a particular investment 
of research time could be made informally, as in our example. In health economic modelling, 
this could be done formally by quantifying the expected health benefits from reduced decision 
uncertainty in economic terms, and trading off with research costs (6). Additionally, if we are in 
a position to conduct a study to collect primary data, the expected value of sample information 
could be used to quantify the expected gains from a study of a specific design and sample size, 
though this is not illustrated here — see, e.g. (9) for an example. 
Health impact models with multiple model variants 
We emphasise that the value of information depends on the chosen model structure (Step 1) 
and outcome of interest (Step 2). This is illustrated in Figure 3. In our example, we examine a 
model that quantifies health impacts of air pollution scenarios in São Paulo. However there are 
multiple variants of that model designed to assess impacts for other cities and countries. Each 
setting requires slightly different data. Some quantities, such as patterns of exposure to 
pollution, may vary between places, whereas other quantities, such as the relative risks of 
disease due to exposure, are assumed to be generic to all settings. Collecting further data on 
such generic quantities would benefit all variants of the model, therefore estimating the full 
value of such data would require an analysis based on an expanded model structure that 
includes all settings. 
Likewise there are typically multiple health outcomes of interest (e.g. deaths averted, 
reductions in health inequality, reduction in burden of a particular disease) and many 
alternative scenarios to examine. If the model is used for an explicit decision between policies, 
then we can define VoI as in Equation 1. If the model is just used for estimation, we could 
calculate a different VoI (Equation 2) corresponding to each outcome and scenario, or define 
the VoI based on some overall measure of uncertainty. 
 
Figure 3. Illustration of how the value of learning a particular input parameter depends on the 
choice of model structure and outcome of interest. In this hypothetical model, learning the 
relative risk of stroke associated with pollution improves information about health gains in São 
Paulo and London, whereas learning the air pollution concentration in São Paulo will only 
improve information on São Paulo-specific outcomes. The expected value of information also 
depends on the definition of the disease outcome of interest, and the air pollution reduction 
scenario examined. 
Using VoI to guide improvement of a health impact model 
Here we demonstrate how VoI can be used to prioritise model improvements, in a hypothetical 
example, which is fully described in the Appendix. The example is adapted from the published 
ITHIM São Paulo (14) by using the original model structure, but starting with very broad 
distributions on the parameters (explained in the Appendix), in order to imitate the typical 
development of a health impact model in a new setting where an appropriate structure has 
been decided but the parameters are not known.  We then show how VoI methods could be 
used to prioritise which parameters should be learnt better, and how hierarchical models can 
be used to inform parameters from multiple sources of indirect data.  The example here is 
artificial and serves to demonstrate the methods, rather than as a substantive and thorough 
health impact analysis. 
The model estimates the change in the burden of disease due to pollution exposure, for each 
disease and scenario, by age group and gender. To apply VoI, we choose the outcome of 
interest to be the reduction in the number of deaths per year from any cause, over all age and 
gender groups, under a scenario (“SP2040”) defined as the “best case” for São Paulo in 2040 
(14). We follow the process above, calculating the EVPPI for each parameter as the expected 
reduction in variance of this outcome if the parameter were to be learnt precisely. The EVPPI 
for each parameter is compared to the expected costs of research (in person–days) to obtain 
better information on the parameter. Research is undertaken if the potential precision 
reduction was thought to be worth the research cost, according to an informal judgement. 
For all the parameters in our example, further research is judged to be possible that would 
involve searching literature for additional data and constructing a statistical model (Table 1). 
This kind of research is predicted to take 2–5 person-days per parameter in our example, but in 
other examples this may vary. In other situations, research of this kind may not be possible, and 
obtaining further data would require primary data collection (e.g. local air-pollution 
monitoring), which would be substantially more expensive. 
 
For our example, we informally allocate a research “budget” of ten person–days. With this 
budget, we aim to maximise expected reduction in outcome uncertainty.  The costs of research, 
and the actual amount of information (compared to “perfect information”) gained from the 
research will not be possible to predict exactly in practice; therefore, informal judgements are 
usually required to make this trade-off. Although the need to make informal judgements may 
make the approach sound less scientific, it is important to remember that modelling requires 
laying out clearly assumptions made regarding data and evidence. The alternative would be to 
make such decisions implicitly without laying out the assumptions (31). 
 
Results 
Under the initial set-up of the model, we estimate the expected number of deaths prevented 
per year in the SP2040 scenario to be 189.4, with a standard deviation of 196.0. 
 
The EVPPI and the expected cost of further research for each parameter are presented in Table 
1. The two parameters with the highest EVPPI are ζ, the proportion of air pollution attributable 
to road traffic, and η, the background level of air pollution, both pertaining to São Paulo. As we 
anticipated that five days of work would provide substantially better information for each 
parameter, and given our ten person–day budget, we choose to obtain further data on these 
parameters. 
Learning the exact value of 𝜁𝜁 could be expected to reduce the variance of the number of deaths 
averted by up to 48%, from 38,000 ≈ 196.02 to 20,000 ≈ 140.72, while learning 𝜂𝜂 would be 
expected to reduce the variance by 12%. Literature is then searched for data, followed by 
statistical modelling, to obtain better-informed estimates of 𝜁𝜁 and 𝜂𝜂 respectively.  The data to 
inform 𝜁𝜁 and 𝜂𝜂 consist of alternative published estimates of the proportion of air pollution from 
road traffic within São Paulo, and the data for 𝜂𝜂 consist of estimates of background pollution for 
other cities and countries.  Bayesian hierarchical modelling is used to produce posterior 
distributions quantifying the updated beliefs about 𝜁𝜁 and 𝜂𝜂, informed by the variability 
between the published estimates.  Full details of these models are given in the Appendix.  
After this research, we estimated the number of deaths prevented to be 223.3, with standard 
deviation 132.4, which is judged to be sufficiently precise, given the likely cost of further 
research. 
 
 
 
Table 1. Expected value of partial perfect information (expressed in two different ways) and 
expected amount of research required for improved information, for each parameter in the 
example air pollution health impact model . 
Parameter Description 
EVPPI expressed as:  Expected 
person–
days of 
work for 
improved 
information 
Predicted reduction 
in standard 
deviation describing 
uncertainty in 
number of deaths 
prevented 
Percentage of 
outcome variance 
explained by 
parameter 
uncertainty 
𝜂𝜂 Background air pollution 12.2 14.68 5 
𝜁𝜁 Traffic proportion of air 
pollution 
55.2 48.20 5 
𝛼𝛼 Proportions of traffic 
pollution emissions from 
each mode 
3.4 7.53 5 
𝜆𝜆𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤 Walking ventilation rate 9.4 7.50 3 
𝜆𝜆𝑐𝑐𝑐𝑐𝑐𝑐𝑤𝑤𝑐𝑐 Cycling ventilation rate 0.3 0.43 2 
 Uncertainty in dose–
response curve for relative 
risk of disease as a function 
of air pollution: 
   
𝜉𝜉𝑠𝑠𝑠𝑠𝑟𝑟𝑠𝑠𝑤𝑤𝑐𝑐 Stroke 0.3 3.82 5 
𝜉𝜉𝐼𝐼𝐼𝐼𝐼𝐼 Ischaemic heart disease 2.7 3.35 5 
𝜉𝜉𝐿𝐿𝐿𝐿  Lung cancer 0.2 1.38 5 
𝜉𝜉𝐿𝐿𝐶𝐶𝐶𝐶𝐼𝐼 COPD 1.7 0.68 5 
 Discussion 
We have presented a procedure for prioritising research to reduce uncertainty in health impact 
simulation models. VoI methods are used to identify which model inputs contribute most to the 
uncertainty about the outputs. This allows the model developer to decide where to focus 
resources to improve the model, given the cost of doing research for each model input. Such 
methods might be particularly helpful for prioritising research to inform policy making in 
contexts with limited data (e.g. low and middle-income countries).  In the pollution and health 
example, VoI identified two particularly uncertain parameters describing pollution levels and 
sources, which were subsequently informed using hierarchical modelling of related data, 
leading to estimates of health impacts with a 50% improvement in precision.  
Once uncertainties have been quantified probabilistically, no further assumptions are necessary 
to obtain the potential value of further information on each parameter, which follows naturally 
through decision-theoretic principles. A more common approach to research prioritisation is 
one-way sensitivity analysis, that is, comparing a model output for alternative values of the 
input. This depends on an arbitrary choice of alternative values, and may be misleading if the 
relationship of the input to the output is nonlinear.  While simple sensitivity analysis is 
necessary if we are not able to even roughly quantify the true extent of uncertainty about a 
model input, we would argue that statistical methods, such as hierarchical models, can be used 
to quantify uncertainty in many more cases than in current practice. 
Note that the estimates of VoI are conditional both on the model structure, outputs of interest, 
and on the distributions chosen for the input parameters. If the model structure is uncertain, it 
could be extended to include parameters that represent different plausible structural 
assumptions, as in (27). This allows VoI to be used to prioritise research to refine the model 
structure. In our case study, VoI analysis was based on a single output of interest. More 
experience is needed on using VoI for research prioritisation when there are several outputs of 
interest, and several modelling settings and scenarios to be considered. 
The models we have described estimate population-average outcomes as a complex function of 
a set of input parameters. VoI analysis is enabled by defining distributions that quantify 
uncertainty on the input parameters. As outlined in (32), there are many alternative structures 
for health policy simulation models, and one of these is “microsimulation”, which works by 
simulating outcomes for a large population of synthetic individuals, and then taking an average. 
In these, uncertainty is sometimes not expressed explicitly by placing distributions on inputs, 
but implicitly, through using a finite sample of observed individual-level data to generate the 
synthetic population (see (33) for an example). Calculating the value of information in this 
context would be challenging — though could be done in theory by defining a parametric 
model from which synthetic individuals could be sampled. 
Note that the consequences of overestimating and underestimating uncertainty are different. If 
uncertainty for an input is overestimated, but the VoI is still low, we can be confident that 
further research on that input would not be worthwhile, whereas if the VoI is high, we will 
obtain better evidence. On the other hand, if we underestimate uncertainty, VoI analysis might 
tell us wrongly that further research is not needed. Thus we recommend being ‘generous’ or 
‘conservative’ in assigning uncertainty to parameters, if the priority is to obtain a better 
evidence base for decision making. Any new evidence obtained from research may have value 
beyond the decision model it was originally obtained for. 
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A guide to Value of Information methods 
for prioritising research in health impact 
modelling: Appendix. 
1. The pollution and health impact model 
 
Code to implement this example is available at 
https://github.com/robj411/value_of_information_example. 
The calculations relating the model input parameters to the expected number of deaths 
averted in the example pollution and health impact model, adapted from (14) are given in 
this appendix. Greek letters denote parameters that are uncertain. Upper-case Roman 
characters refer to data sets, computed quantities, and functions. Many of these quantities 
are computed by subgroups, defined by combinations of five variables, indexed by lower-
case Roman characters as described in Table 1. 
Table 1. Indices used in the ITHIM variables 
Label Values 
a Age group 
d Disease 
g Gender 
m Transport mode: 
 Walking 
 Cycling (cyc.) 
 Bus 
 Car 
 Motorbike (mot.) 
 Goods vehicles (GV) 
s Scenario 
 
Parameter values 
The model structure from (14) was used, but we start afresh with choosing parameter 
values, in order to emulate a typical situation in health impact modelling where we wish to 
use an existing model structure in a new setting, and to demonstrate how Value of 
Information analysis might then be used to prioritise research to inform the model 
parameters.  
Initially, we choose prior distributions for parameter values that cover the range we believe 
each value could plausibly take. For example, for 𝜂 and 𝜁, we can use World Health 
Organisation (WHO) tables that include data from all over the world to guide us towards 
what values would be plausible. 
The background PM2.5 concentration for a city, 𝜂, ranges between 1.6–217, with all cities in 
Latin American countries having values below 50, so we use a log-normal distribution with 
mean 3 and standard deviation 1 on the log scale (Figure 1, right, grey). The proportion of 
PM2.5 pollution attributed to transport in a related WHO database ranges from 0% to 85% 
(including dust, the range is 0% to 91%). The value given for São Paulo is 23.5% (51%, 
including dust). Thus, we choose Beta(2,3) as the prior distribution for 𝜁 (Figure 1, left, grey). 
For 𝛼, we first consult a recent CETESB report1 for the Metropolitan area of São Paulo. 
These are estimates of contributions to particulate matter of different vehicle types. Cars, 
buses, motorcycles and goods vehicles are estimated to contribute 32%, 4%, 4%, and 60%, 
respectively. A Dirichlet(32, 4, 4, 60) distribution is used as the initial belief about the vector 
𝛼 of these four proportions, which encodes a prior expectation centred around these 
published values, but with some uncertainty, as illustrated in Figure 2. 
For the 𝜆 values, we consult The Compendium of Physical Activity2. Estimates for walking 
METs vary from 2 to 12, and for cycling from 3 to 17. For our model, we use marginal METs 
(MMET = MET – 1). For these values we choose log-normal distributions, so that they are 
greater than zero and peak earlier in the range. These distributions are shown in Figure 3. 
The parameters 𝜉𝑑 express uncertainty about the dose–response curves 𝐻𝑑(𝑥) (Figure 4), 
defined as the relative risk of mortality from each of four diseases 𝑑 associated with an 
increase of 𝑥 in air pollution exposure. They are assumed to be measured with some degree 
of uncertainty, quantified by 𝜉𝑑. Specifically the true relative risk is defined as 𝜉𝑑𝐻𝑑(𝑥), 
where 𝜉𝑑 has a log-normal distribution with mean 0 and standard deviation 0.5, thus it is 
centred around 1. This represents the belief that the relative risk does not go below 1, and 
that the actual value is between 50% and 200% of the reported values (see Figure 4). 
The average time spent travelling, the population composition, and the baseline burden of 
disease are treated as constants for the purpose of this illustration, though in practical 
applications they might be treated as uncertain. 
 
                                                      
1   Table 5 of https://cetesb.sp.gov.br/veicular/wp-
content/uploads/sites/6/2013/12/Plano_de_Controle_de_Poluicao_Veicular_do_Estado_de
_Sao_Paulo_2014-2016.pdf, where we include “business” in the “heavy goods” category. 
2  
 https://sites.google.com/site/compendiumofphysicalactivities/references 
 
 
 
 
Figure 1. Distributions for 𝜁 and 𝜂 in the pollution module. In grey are the original vague prior 
distributions: left, the proportion of air pollution attributed to traffic, 𝜁 ∼ 𝐵𝑒𝑡𝑎(2,3), and right, 
the mean background air pollution level for cities within Brazil, 𝜂 ∼ 𝐿𝑜𝑔𝑛𝑜𝑟𝑚𝑎𝑙(3,1). In orange 
are the posterior distributions given the additional data. The right panel also shows the 
posterior distributions for background pollution for predicted cities in two other countries in 
the lower–middle income American region: Peru and Paraguay. 
  
Table 2. Parameters of the pollution and health impact model, with prior distributions 
Name Description Prior distribution 
   
𝑇𝑎,𝑔,𝑚,𝑠 Minutes spent travelling per day Constant 
𝑁𝑎,𝑔 Population number Constant 
𝑈𝑎,𝑑,𝑔,𝑜=𝑑𝑒𝑎𝑡ℎ Background burden of disease: deaths per age, 
gender and disease 
Constant 
   
𝜂 Background PM2.5 concentration Log-normal(3,1) 
𝜁 Fraction of 𝜂 attributed to road transport Beta(2,3) 
𝛼 Fraction of 𝜁 attributed to four different modes 
(bus, car, motorcycle, goods vehicles) 
Dirichlet(32,4,4,60) 
   
𝜆𝑚=𝑤𝑎𝑙𝑘 Walking MMET
3 Log-normal(1,1) 
𝜆𝑚=𝑐𝑦𝑐. Cycling MMET Log-normal(2,0.4) 
   
𝐻𝑑(𝑥) Relative risk of disease (Figure 1) Function of PM2.5 
exposure 
𝜉𝑑=𝐴𝐿𝑅𝐼 Uncertainty in ALRI
4 relative risk Constant (1) 
𝜉𝑑=𝐶𝑂𝑃𝐷 Uncertainty in COPD
5 relative risk Log-normal(0,0.5) 
𝜉𝑑=𝐿𝐶  Uncertainty in lung cancer relative risk Log-normal(0,0.5) 
𝜉𝑑=𝑠𝑡𝑟𝑜𝑘𝑒 Uncertainty in stroke relative risk Log-normal(0,0.5) 
𝜉𝑑=𝐼𝐻𝐷 Uncertainty in IHD
6 relative risk Log-normal(0,0.5) 
                                                      
3     Metabolic equivalent, kcal/kg/hr (41) 
4     Acute lower respiratory illness 
5     Chronic obstructive pulmonary disease 
6     Ischaemic heart disease 
 Figure 2. Distributions for α, the proportion of traffic pollution attributed to each mode. 
 Figure 3.Distributions for λ, the MMET values associated with active travel. 
 Figure 4. Relative risk of disease, 𝐻𝑑(𝑥), for five diseases 𝑑 and PM2.5 exposure 𝑥 from zero 
to 200, from (34). 𝐻𝑑(𝑥) expresses the risk of disease 𝑑 between two individuals whose 
PM2.5 exposure differs by 𝑥. The value for 𝑥 will be different in each scenario; the quantity 
necessary to calculate the burden of disease is the value of 𝐻𝑑(𝑥) relative to the baseline 
scenario value. This relative risk multiplies the background burden of disease to give the 
scenario burden of disease. Dashed lines show 90% uncertainty intervals implied by the 
parameters 𝜉𝑑.  
 
Model calculations 
Here we describe all calculations in the model that map the input parameter values to the 
outcome, which is the disease burden in terms of the number of deaths. 
Population travel 
First, the total time spent travelling is a product of the population numbers and the average 
time spent travelling per demographic group, per mode of transport and scenario. 
𝐴𝑎,𝑔,𝑚,𝑠 = 𝑁𝑎,𝑔 ⋅ 𝑇𝑎,𝑔,𝑚,𝑠. 
Then the total time spent travelling per mode and scenario is the sum over the demographic 
groups: 
𝐴
̃
𝑚,𝑠 = ∑𝐴𝑎,𝑔,𝑚,𝑠
𝑎,𝑔
. 
Finally, we calculate the total time spent travelling per mode and scenario relative to the 
baseline: 
𝐴
̂
𝑚,𝑠 = 𝐴
̃
𝑚,𝑠 𝐴
̃
𝑚,𝑠=𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒⁄ . 
Air pollution calculations 
First, we calculate the fold change in air pollution by mode, given the population travel 
pattern, for the motorised modes which contribute to pollution emissions, 𝑚 ∈
{𝑏𝑢𝑠, 𝑐𝑎𝑟,𝑚𝑜𝑡. , 𝐺𝑉}: 
𝑃
̃
𝑚,𝑠 = 𝐴
̂
𝑚,𝑠 ⋅ 𝛼𝑚, 
and sum over the modes to get the fold change in total transport-related air pollution: 
𝑃
̂
𝑠 = ∑𝑃
̃
𝑚,𝑠
𝑚
. 
We use this to calculate the fold change in background concentration of air pollution, given 
the proportion attributable to traffic: 
𝑃𝑠 = 𝜂 (1 − 𝜁 (1 − 𝑃
̂
𝑠)). 
Ventilation rate calculations 
We define ventilation rates for the different modes, relative to ventilation when not 
travelling, as follows: 
𝑉𝑚=𝑤𝑎𝑙𝑘 1 + 𝜆𝑚=𝑤𝑎𝑙𝑘;
𝑉𝑚=𝑐𝑦𝑐. 1 + 𝜆𝑚=𝑐𝑦𝑐.;
𝑉𝑚=𝑏𝑢𝑠 1.5;
𝑉𝑚=𝑐𝑎𝑟 1.5;
𝑉𝑚=𝑚𝑜𝑡. 2;
𝑉𝑚=𝐺𝑉 1.5.
 
Then, for each mode, we calculate the total ventilation rate in traffic, given each 
demographic group’s travel pattern: 
𝑉
̃
𝑎,𝑔,𝑚,𝑠 = 𝑉𝑚 ⋅ 𝑇𝑎,𝑔,𝑚,𝑠. 
The total ventilation rate per demographic group per scenario sums over time spent in 
traffic and that spent not in traffic: 
𝑉
̂
𝑎,𝑔,𝑠 = (1,440 −∑𝑇𝑎,𝑔,𝑚,𝑠
𝑚
+∑𝑉
̃
𝑎,𝑔,𝑚,𝑠
𝑚
) 1,440.⁄  
Finally, the exposure to air pollution is calculated as the product of ventilation and 
background air pollution concentration: 
𝑉
̌
𝑎,𝑔,𝑠 = 𝑉
̂
𝑎,𝑔,𝑠 ⋅ 𝑃𝑠. 
Health impact calculations 
Health impacts are calculated by standard comparative risk assessment methods (see, e.g. 
(35)). We calculate the relative risk of disease given air pollution exposure as 
𝐻
̂
𝑎,𝑑,𝑔,𝑠 = 1 + 𝜉𝑑 ⋅ (𝐻𝑑 (𝑉
̌
𝑎,𝑔,𝑠) − 1), 
where 𝜉 defines the uncertainty about the dose–response relationship. 
We calculate the relative risks between scenario 𝑠 and baseline as 
𝐻
̌
𝑎,𝑑,𝑔,𝑠 = 𝐻
̂
𝑎,𝑑,𝑔,𝑠 𝐻
̂
𝑎,𝑑,𝑔,𝑠=𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒⁄ . 
This ratio is used to scale the baseline burden of disease, to obtain the disease burden for 
each scenario, as follows: 
𝑈
̃
𝑎,𝑑,𝑔,𝑠 = 𝐻
̌
𝑎,𝑑,𝑔,𝑠 ⋅ 𝑈𝑎,𝑑,𝑔. 
Finally, we sum over the demographic groups to get the total burden of disease, which we 
count in number of deaths from the avoidable causes that are modelled, for the population 
of Sao Paulo, per year. 
𝑑𝑒𝑎𝑡ℎ𝑠 = 𝑈
̂
𝑠 = ∑ 𝑈
̃
𝑎,𝑑,𝑔,𝑠
𝑎,𝑑,𝑔
. 
 
  
2. Calculating the expected value of partial perfect information 
(EVPPI) 
The EVPPI can be estimated, given a sample of values from the uncertainty distributions of 
the model inputs, and a corresponding sample for the model outputs, by using regression. 
The method of (13) is used here, as adapted in (9) for cases where the EVPPI is defined as an 
expected reduction in variance. The following regression model is fitted, where 𝑌(𝑟) are the 
sampled values of the outcome 𝑌, 𝑋𝑖
(𝑟) are the corresponding samples of the input 
parameter(s) of interest 𝑋𝑖, 𝜖𝑟 is a noise term, and 𝑔( ) is a flexible, non-linear function. 
𝑌(𝑟) = 𝑔(𝑋𝑖
(𝑟)) + 𝜖𝑟 , 𝑟 = 1,… , 𝑅 
Then 𝐸𝑋𝑖(𝑣𝑎𝑟(𝑌|𝑋𝑖)) is estimated by the mean of the squared residuals  from this 
regression, where 𝑔
^
( ) is the fitted regression function. For 𝑔( ), we use generalised 
additive models, via the gam function in the mgcv R package, as in the following R code. Y is 
the vector of length 𝑅 containing the sample of model outputs, and Xi is the corresponding 
vector of sampled values for the input parameter of interest. 
    library(mgcv) 
    g.hat <- gam(Y ~ s(Xi)) 
    EVPPI.xi <- var(Y) - mean((Y - g.hat$fitted)^2) 
To learn the expected value of learning more than one parameter simultaneously, for 
example two parameters Xi,Xj, the univariable regression is extended to a multivariable 
regression: 
    g.hat <- gam(Y ~ te(Xi,Xj)) 
Note that the method in (36) calculates this expected variance reduction via a different 
route, though is not easily applicable (9) when Markov Chain Monte Carlo simulation is used 
to estimate the parameters of a Bayesian statistical model, as in our example. 
  
3. Meta-analysis of proportion of air pollution attributable to road 
traffic 
We obtain information about 𝜁 using three data sources, giving estimates of: 40% (37), 30% 
(38), and 60% (39), labelled 𝑦𝑖 for studies 𝑖 = 1,2,3. The data were produced in different 
years (2007–8, 2003 and 2011–2014 respectively), at three different locations using three 
different methods. The quantity of interest for our model is a city-level average for the year 
2016.  
We construct a Bayesian hierarchical meta-analysis model (40) to relate this quantity to the 
observed data. For simplicity, the observed estimates 𝑦𝑖 are assumed to be logit-normally 
distributed around the true city-level average 𝜁, that is 𝑙𝑜𝑔𝑖𝑡(𝑦𝑖) ∼ 𝑁(𝑙𝑜𝑔𝑖𝑡(𝜁), 𝜏
2). We use 
our originally assigned distribution for the prior distribution, which is 𝑒𝑡𝑎(2,3) , 
representing a belief that 𝜁 is between 6% and 81%  with 95% probability (Figure 1). The 
between-source standard deviation on the logit scale, 𝜏, is given a positive-truncated 
Normal(0,1) prior, which represents a belief that 𝜏 is between 1% and 30% with 95% 
probability. 
Samples from the resulting posterior distribution of 𝜁 are generated by Markov Chain 
Monte Carlo methods, using the software Stan (42). The prior and posterior densities are 
illustrated in Figure 1 (left). Given only three observations, the posterior will be influenced 
by the exact choice of prior. However Figure 1 (left) shows that it acknowledges that the 
true 𝜁 may be similar to any of these three observations. This rough analysis is sufficient for 
research prioritisation — a more detailed analysis might account for observed 
characteristics of each data source, e.g. using regression, and explore alternative statistical 
assumptions.  
 
 
 
 
  
  
4. Hierarchical models to estimate the background air pollution 
concentration 
We suppose we do not have any direct data for the background concentration of PM2.5, 𝜂, 
for São Paulo. Instead, we use World Health Organisation (WHO)--published estimates for 
the background PM2.5 concentrations 𝜂 g/𝑚3. We use data from 2016 that cover 2,972 
cities worldwide.7 We illustrate how a hierarchical model (also known as a multi-level or 
mixed effects model) can make use of this information to form an uncertainty distribution 
for 𝜂. 
 
Figure 5. The hierarchical model used to infer the background level of air pollution for São 
Paulo. Blue boxes represent measurements from cities all over the world, which are related 
by the country they are in, which are related by the region they are in. Ovals represent 
distributions that we will learn from the data. Ellipses denote additional locations not shown. 
There are, in the dataset, ten regions, 104 countries, and 2,972 cities. 
 
Each city 𝑖 belongs to one of 104 countries 𝑐, and each country belongs to one of ten regions 
𝑟. Brazil is in the lower–middle income Americas region (LMI Amr), which contains 102 
measurements from cities in 13 countries (see Figure 5). The published city-specific 
estimates 𝑦𝑖𝑐𝑟 are assumed to be generated from a (log-)normal distribution centred around 
country-level means 𝜃𝑐𝑟. A second and third level of the model similarly define country-level 
means in terms of a regional mean 𝜃𝑟
(𝑅), and the regional means in terms of a global mean 
𝜃(𝐺).   Formally:  
                                                      
7   http://www.who.int/phe/health_topics/outdoorair/databases/cities/en/ 
𝜃(𝐺) ∼ 𝑁(0, 52)
𝜃𝑟
(𝑅) ∼ 𝑁 (𝜃(𝐺), (𝜏(𝐺))
2
) , 𝑟 = 1, . . , 𝑁(𝑅)
𝜃𝑐𝑟
(𝐶) ∼ 𝑁 (𝜃𝑟
(𝑅), (𝜏(𝑅))
2
) , 𝑐 = 1, . . , 𝑁𝑟
(𝐶)
𝑙𝑜𝑔(𝑦𝑖𝑐𝑟) ∼ 𝑁 (𝜃𝑐𝑟
(𝐶), (𝜏(𝐶))
2
) , 𝑖 = 1, . . , 𝑁𝑐𝑟
𝑙𝑜𝑔(𝜂) ∼ 𝑁 (𝜃𝑐𝑟
(𝐶), (𝜏(𝐶))
2
) 𝑓𝑜𝑟𝑐, 𝑟𝑖𝑛𝑑𝑖𝑐𝑎𝑡𝑖𝑛𝑔𝐵𝑟𝑎𝑧𝑖𝑙
 
Standard half-normal prior distributions are used for the standard deviation parameters 
𝜏(𝐶), 𝜏(𝑅), 𝜏(𝐺), representing a 95% prior credible interval of about (0.03, 2.2) for the 
standard deviation at each level. 
The unknown São Paulo value 𝜂 is assumed to be generated from the Brazil-specific country-
level distribution. The posterior distribution of 𝜂 will principally reflect the variation 
between other cities in Brazil, but also include, less directly, information from the other 
regions and countries in the world. This is illustrated in Figure 1 alongside the posterior 
distributions for predicted cities in two other countries in the lower–middle income 
American region, Peru and Paraguay. 
This relatively simple example serves to illustrate the basic principles — a more elaborate 
model might include information about observed characteristics of São Paulo that are 
predictive of the air pollution levels (e.g. size or population density), multiple measures from 
the same city, or correlations in space and time. See e.g. (43) for a sophisticated example of 
hierarchical modelling of global pollution. 
 
